COMBINATION OF NITROUS OXIDE AND 5-HT2A RECEPTOR AGONISTS Application WO-2023186963-A1 World Intellectual Property Organisation (WIPO) 05 Oct 2023
INJECTABLE AND INHALABLE FORMULATIONS Application WO-2023089132-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
COMBINATION DRUG THERAPIES Application WO-2023036473-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
INJECTABLE FORMULATION Application WO-2022043227-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022